Martha Stewart’s appearance in a new advertisement for Eli Lilly’s GLP-1 weight-loss drug Foundayo is drawing attention because the ad expressly discloses that Stewart does not take the medication herself. The campaign has sparked debate about celebrity pharmaceutical endorsements and whether a spokesperson needs to personally use a medication they promote.
Edgar J. Asebey provided HuffPost with insight into the FDA rules governing pharmaceutical advertising, explaining that the agency’s focus is on whether required information is appropriately communicated to consumers, not whether a celebrity spokesperson uses the drug. Lilly discloses that Stewart does not use Foundayo, directs consumers to consult their physicians and provides information about potential side effects. “That’s what the FDA is interested in,” Asebey told HuffPost. He also noted that pharmaceutical companies can use a celebrity’s audience and image to build awareness and positive associations with a product, illustrating the intersection of FDA advertising requirements and pharmaceutical marketing strategy.
